“leber-congenital-amaurosis-type-10” Archives

in
Entry Author Date Location
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter 10/06/20 San Francisco
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Page 1 of 1